Key result
Perceval sutureless aortic valve replacement yields a ~2% 30-day mortality rate with high procedural success.
Why the study?
The safety and performance of the Perceval sutureless valve in aortic valve replacement patients required evaluation through early clinical outcomes.
What are the 30-day clinical outcomes and safety of the Perceval sutureless valve in patients undergoing aortic valve replacement?
Comparison
No comparator, single-arm evaluation of Perceval sutureless valve
Design
Retrospective cohort study
Follow-up
30-day
Authors
Loading...
May support Perceval use in selected aortic cases; observational data leaves open need for randomized durability comparisons.
Cohort (n=139)
What are the 30-day clinical outcomes and safety of the Perceval sutureless valve in patients undergoing aortic valve replacement?
Early postoperative results indicate that the Perceval sutureless aortic valve is safe and has acceptable hemodynamic performance at 30 days.
Mujtaba et al. (2018) conducted a cohort in Aortic valve replacement (n=139). Perceval sutureless aortic valve was evaluated on 30-day mortality. The Perceval sutureless aortic valve was successfully implanted in 97.1% of patients undergoing aortic valve replacement, with a 30-day mortality rate of 2.1%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: